MMP2 and polycystic ovary syndrome: Metformin reduced H19 expression by promoting methylation of the H19 promoter and inhibited expressions of MMP-9 and MMP-2 via the H19/microRNA (miR)-29b-3p pathway, thereby alleviating PCOS severity [21].